美股A股
StockGist
Back
10-Q2026-05-01· glm-5

IRMD · IRadimed Corporation

0001628280-26-029325

SEC filing

Summary

Revenue was $22.0M (12.7%) Gross Profit was $16.8M (13.3%) Operating Income was $7.2M (33.2%) Net Income was $5.8M (24.1%)

Key takeaways

Full analysis

Revenue Performance and Business Drivers

Profitability and Operating Leverage

Cash Flow and Capital Allocation

Net cash provided by operating activities was $8.3M, a substantial increase from the prior year. After capital expenditures of $0.4M, the Company generated free cash flow of $7.9M. Management noted that principal uses of cash include operating expenses, working capital requirements, capital expenditures, and dividend payments. The Company maintains that it does not anticipate requiring additional capital, citing historical liquidity from cash balances and cash flow from operations.